Selected article for: "cc international license and current study"
Author: Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Zhibing Lu; Stella K Kang; David Fenyo; Timothy Alcorn; Isaac P Dapkins; Iman Sharif; Deniz Vurmaz; Sayli S Modak; Kritika Srinivasan; Shruti Warhadpande; Ravi Shrivastav; John T McDevitt
Title: Clinical Decision Support Tool and Rapid Point-of-Care Platform for Determining Disease Severity in Patients with COVID-19
  • Document date: 2020_4_22
    • ID: h4lsvgxo_12
    Snippet: While the fully integrated point-of-care instrumentation has been described previously, 23 for this current study the instrument was configured into a modular fixture for experimentation and assay development. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: While the fully integrated point-of-care instrumentation has been described previously, 23 for this current study the instrument was configured into a modular fixture for experimentation and assay development. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • assay development and cc NC ND International license: 1, 2
    • assay development and current study: 1, 2, 3
    • assay development and International license: 1, 2
    • care point and cc NC ND International license: 1, 2
    • care point and current study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • care point and International license: 1, 2
    • care point and previously describe: 1, 2, 3
    • cc NC ND International license and current study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • current study and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19